logo
logo
Sign in

How Is Fibrin Glue Market Driven by Rising Appearance Consciousness?

avatar
Pramod Kumr
How Is Fibrin Glue Market Driven by Rising Appearance Consciousness?

The global fibrin glue market is projected to attain a sufficient CAGR in the coming years. There are several factors that are responsible for the market’s rapid growth, such as the growing number of surgical procedures, rising burn cases, and increasing healthcare expenditure. In addition, an aging population, rising incidence of road accidents, low chances of complications associated with these products, and an advancing prevalence of chronic diseases are driving the consumption of such materials in the healthcare sector.


The worldwide fibrin glue market stands to benefit greatly from the improving healthcare ecosystem in emerging economies. Because of the increase in the government spending, growth in the number of hospitals, rise in the number of operational procedures, and greater healthcare awareness, the healthcare business in developing nations is undergoing significant changes. Additionally, the already advanced healthcare sector in developed countries presents lucrative opportunities for the growth of the market.


Patients suffering from different diseases are increasingly opting for surgeries for better and faster treatment, which is leading to a rise in the use of fibrin glues. As the incidence of numerous health problems and chronic diseases rises, so does the number of operations conducted across the world, thereby driving the fibrin glue market advance. For instance, over 40% of the school-going children and adolescents in the U.S. have at least one chronic health condition, says the CDC.


To provide more-advanced solutions for hemostasis in surgical settings, major players in the global fibrin glue market are partnering and acquiring other players' product portfolios. RECOTHROM Thrombin Topical (recombinant), RAPLIXA (human fibrin sealant), and PreveLeak Surgical Sealant are among the leading players in the industry. Some other major companies include Hualan Biological Engineering Inc., Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Plc, Takeda Pharmaceutical Company Limited, Zimmer Biomet Holdings, Inc., CSL Behring, Baxter International Inc., Johnson & Johnson, Kaketsuken, and Vivostat A/S.


Hence, due to the government investment in the health sector, the market has tremendous advancement potential.



collect
0
avatar
Pramod Kumr
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more